79,521 shares purchased by the Martingale Asset Management L.P. of the Jazz Pharmaceuticals PLC

According to the latest filing with the SEC, the stake in the Jazz Pharmaceuticals PLC was raised by the Martingale Asset Management L.P. by 32.9 percent during the 1st quarter. The funds acquired 320,876 shares of the Jazz Pharmaceuticals PLC after purchasing an extra 79,521 shares during the last quarter. Martingale Asset Management L.P. now owns 0.57 percent of the Jazz Pharmaceuticals PLC which is worth the value of $45,870K by the end of the latest quarter.

Various other investors also have purchased shares of the company. JPMorgan Chase & Co. raised its stake in the shares of the Jazz Pharmaceuticals PLC by 16.7 percent during the 1st quarter. Now it possesses 2,262,159 shares of the pharma company which is valued at $323,376K after getting the acquisition of extra 324K shares during the 4th quarter.

Vanguard Group Inc. raised its position in the shares of the Jazz Pharmaceuticals PLC by 0.5 percent in the 3rd quarter. The company has now the possession of 4,882,984 shares of the pharma company’s stock which is valued at $820,975K after buying an extra 23K shares during the last quarter. Boston Partners raised its position in the stake of the Jazz Pharmaceuticals PLC’s shares by 17.8 percent in the 4th quarter. Boston Partners has now the possession of 1,315,371 shares of the pharma company which is valued at $163,054K after buying an extra 198,306 shares during the whole period.

Lastly, Westfield Capital Management Co. LP raised its stake in the shares of the Jazz Pharmaceuticals PLC by 2.8 percent during the 4th quarter. Westfield Capital Management Co. LP has now the possession of 1,143,835 shares of the pharma company’s stock which is valued at $141,790K after buying an additional 31K shares during the whole period.